30 Sep 2026 - "Daily Current Affairs" Updates

Mumbai-Ahmedabad High-Speed Rail Corridor

Why in News: The Mumbai-Ahmedabad High-Speed Rail Corridor has not progressed at the pace Japan had expected.

What is MAHSR?

• The Mumbai-Ahmedabad High-Speed Rail Corridor is India's first bullet-train corridor.

• It is being developed with Japanese technical and financial assistance using Shinkansen technology.

• The corridor is about 508 km long and connects Mumbai and Ahmedabad through 12 stations.

• The National High-Speed Rail Corporation Limited (NHSRCL) is the implementing agency.

Route

• The corridor passes through Maharashtra.

• It also passes through Gujarat.

• It crosses the Union Territory of Dadra and Nagar Haveli and Daman and Diu.

How is the Project Financed?

• Funding comes from Government of India equity.

• Maharashtra and Gujarat also contribute to the project.

• A long-term, low-interest loan from the Japan International Cooperation Agency (JICA) forms a major part of the financing.

• The project is therefore a major India-Japan infrastructure-financing partnership.

Technology and Safety

• The project uses Shinkansen E5-series technology.

• The source notes that the Shinkansen network has recorded no passenger fatality due to train accidents since 1964.

Quick Recall

• MAHSR -> India's first bullet-train corridor.

• Length -> 508 km.

• Stations -> 12.

• Implementing agency -> NHSRCL.

• Technology -> Japanese Shinkansen E5-series.

• Major financing partner -> JICA.

HEALTH & SCIENCE

2. Rare Diseases and Orphan Drugs

Why in News: The National Conference on Rare Diseases 2026 highlighted the need for innovation, early diagnosis, indigenous research and stronger collaboration to address rare diseases in India.

What is a Rare Disease?

• A rare disease is a debilitating, lifelong disease or disorder affecting a very small proportion of the population.

• The WHO commonly uses a prevalence threshold of 1 case or fewer per 1,000 people.

• However, individual countries may use different definitions based on epidemiology, healthcare capacity and resources.

Examples Mentioned in the Source

• Gaucher disease.

• Pompe disease.

• Phenylketonuria (PKU).

• Osteopetrosis.

• Spinal muscular atrophy (SMA).

• Fabry disease.

• Cystic fibrosis.

• Hemophilia.

• Huntington's disease.

• Wilson's disease.

• Duchenne muscular dystrophy.

• Maple syrup urine disease.

What Causes Rare Diseases?

• They may be genetic.

• They may be congenital.

• They may also be infectious, autoimmune or degenerative.

Why 'Orphan' Diseases and Drugs?

• Rare diseases are also called orphan diseases.

• Medicines developed for them are called orphan drugs.

• The term reflects the historically low commercial incentive to develop treatments for very small patient populations.

• The source states that around 95% of rare diseases have no approved treatment.

Quick Recall

• Rare disease -> affects a very small proportion of the population.

• WHO threshold in source -> <=1 case per 1,000.

• Rare diseases are also called -> orphan diseases.

• Drugs developed for them -> orphan drugs.

• Source figure -> about 95% have no approved treatment.

ECONOMY & FINANCE

3. Rising Sovereign Bond Yields

Why in News: Sovereign bond yields are rising across major economies, including Japan, the United States, the United Kingdom, Germany and India.

What is a Bond?

• A bond is a fixed-income financial instrument.

• An investor lends money to a government, company or other borrower for a specified period.

• In return, the investor receives interest.

Bond Price vs Bond Yield

• Bond prices and bond yields move in opposite directions.

• When the market price of an existing bond falls, its effective yield rises.

• When the bond price rises, its yield falls.

• Therefore, rising sovereign bond yields generally mean higher borrowing costs for governments issuing fresh debt.

Why are Global Bond Yields Rising?

• Persistent inflation: higher oil and commodity prices raise production and transport costs, which can keep inflation elevated and support higher interest rates.

• Geopolitical uncertainty: conflicts such as the West Asia crisis can create energy-price volatility and raise expectations of tighter monetary policy.

• Large fiscal deficits: higher government borrowing increases the supply of sovereign bonds and can push yields higher.

• Rising public debt: higher debt and interest rates increase debt-servicing costs and may require additional borrowing.

• Rising US interest burden: larger interest payments on US public debt have raised concerns about long-term fiscal sustainability.

• Declining demand for US Treasuries: lower holdings by some major foreign central banks can reduce demand, weaken prices and increase yields.

• Reserve diversification: central banks shifting part of their reserves towards assets such as gold may reduce demand for sovereign bonds.

• AI-led capital expenditure: increased borrowing by technology firms for AI infrastructure and data centres can increase competition for global savings and raise the overall cost of capital.

Yield Levels Mentioned in the Source

• Japan's 10-year government bond yield is cited at around 3.08%, the highest in about 30 years.

• The US 10-year Treasury yield is cited at around 5.24%.

• The source notes that UK and German 10-year yields rose by nearly 100 basis points over six months.

• India's 10-year government bond yield has also moved upward.

Quick Recall

• Bond price up -> yield down.

• Bond price down -> yield up.

• Rising yields -> higher borrowing cost for fresh government debt.

• Key drivers -> inflation, fiscal deficits, debt burden, geopolitics, weaker demand and reserve diversification.